about
Structure-antigenicity relationship studies of the central conserved region of human respiratory syncytial virus protein GEGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin ExpressionDifferential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodentsRespiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trialsRespiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells.Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection.Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity.Respiratory syncytial virus (RSV) vaccines--two steps back for one leap forward.Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.Primary airway epithelial cell culture and asthma in children-lessons learnt and yet to come.Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells.De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene.Broad-Spectrum Inhibition of Respiratory Virus Infection by MicroRNA Mimics Targeting p38 MAPK Signaling.Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.In Vitro Modeling of RSV Infection and Cytopathogenesis in Well-Differentiated Human Primary Airway Epithelial Cells (WD-PAECs).Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells.A 3-D well-differentiated model of pediatric bronchial epithelium demonstrates unstimulated morphological differences between asthmatic and nonasthmatic cells.Respiratory Syncytial Virus (RSV): Targeting the G Protein Provides a New Approach for an Old Problem.The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B.Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G protein.Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells.The RNA binding protein La/SS-B promotes RIG-I-mediated type I and type III IFN responses following Sendai viral infection.Pro-inflammatory mediator responses from neonatal airway epithelial cells and early childhood wheeze.Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge.Neonatal human autologous dendritic cells pulsed with recombinant protein antigen prime the generation of non-polarized CD4 T-cell effectors.Report of the 2nd “French Clinical Vaccinology Meeting Jean-Gerard Guillet”: Immunization and respiratory diseasesPulmonary epithelial barrier and immunological functions at birth and in early life - key determinants of the development of asthma? A description of the protocol for the Breathing Together studyPhylogenetic analysis of porcine reproductive and respiratory syndrome virus isolates from Northern IrelandCharacterisation of morphological differences in well-differentiated nasal epithelial cell cultures from preterm and term infants at birth and one-yearThe viral protein corona directs viral pathogenesis and amyloid aggregationSelective interference with P protein binding to paramyxovirus nucleocapsidsOriginal Antigenic Sin and Respiratory Syncytial Virus VaccinesComparative primary paediatric nasal epithelial cell culture differentiation and RSV-induced cytopathogenesis following culture in two commercial media
P50
Q27639833-2F43D00B-1D09-4F25-8FD5-9F127E6241E0Q28551865-3F427D51-AC22-4D4C-A52C-F18865DA4DABQ33870528-334F08E2-B8B5-4617-B7A2-7D7A3720D4CBQ34222406-4C9EDE7E-C627-41F6-BFFC-2BA3349EDA9CQ35761061-2D3930F3-E631-45F9-AAC5-6C516A1E7E41Q36277167-41429C17-6D4F-4C88-9ED6-537432FC3C31Q36438987-A311E2DE-3E1C-48CA-B680-06DD844F03C4Q37027756-AEAA3736-248C-4C42-A5C3-77F54AC8BD32Q37110057-B155C217-7A97-4D50-8455-C1915E9A1DF2Q37607079-4E951D6C-CFF8-4AB8-A4C5-97850D179AEFQ38547940-1709E0B3-36BA-4FDA-9C02-47D7562F36FBQ39789193-7A9085BF-9433-4D76-9877-CB8B20209BBAQ39904851-978B7340-6B9F-4C79-8C97-CA081E1516B5Q40156244-0431B58D-7256-4C69-89D2-F459DB107157Q40179439-012BA4E1-9200-4CC3-A746-278E34EC4B52Q40216566-C9E6F514-E50D-4FC0-B3B7-76A1BD481D8BQ40480803-73109C67-E8C6-4C2B-8FF7-AE89E27D0414Q40597774-2257BA84-0E71-4292-BF28-6009F562B485Q41730559-E2299152-14A0-456A-8796-EE5F4008D36FQ43276262-5A67BF5B-A0EA-4072-A734-A56CF51BDF92Q45325102-89F87064-DC51-48CE-843D-5AAF657E098BQ45709995-E95A1834-F020-465E-9C4E-8FFE730426C9Q45738172-21A103CA-1571-4855-9374-79E77DEA7AE2Q45790001-057B9B82-EFB8-480D-9EE9-2E638BD33B12Q46776464-3B5F7552-F4C0-4143-AA86-B128B5659617Q47404814-789A974A-39CA-4BA5-8F0F-6F3279754112Q47435138-DF496529-D3BA-4A2B-8B46-5A95C84F33F4Q51975379-AED9E96E-5E32-471F-9872-CD4DE733BAD8Q56833872-D1CA6173-61C5-41CC-9E30-5F83F80A6631Q57137018-7CD0343E-338C-4460-96BF-2DFB838E6A67Q59360260-E5659421-5D54-4CA3-B4DC-1DD763A82547Q60046595-747940B0-0B95-47A6-B1F1-1D3CEDA9A469Q64286426-EF6547D5-CE16-491C-BFF7-8AFBDED65896Q71645015-3E81382D-D2D9-40C8-B29D-C272AFFA22C1Q89993503-E795BC04-9BFA-4245-BA86-0BC4AA9825A5Q90665961-22DF35DC-C4B2-4B10-981F-97A2DE539789
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ultan F. Power
@ast
Ultan F. Power
@en
Ultan F. Power
@es
Ultan F. Power
@nl
Ultan F. Power
@sl
type
label
Ultan F. Power
@ast
Ultan F. Power
@en
Ultan F. Power
@es
Ultan F. Power
@nl
Ultan F. Power
@sl
prefLabel
Ultan F. Power
@ast
Ultan F. Power
@en
Ultan F. Power
@es
Ultan F. Power
@nl
Ultan F. Power
@sl
P106
P1153
6603755460
P21
P2798
P31
P496
0000-0003-3246-3774